Get to know what's happening behind the scenes.

Learn more



Read the latest on our blog. Let's Talk Innovation.


Stay connected with us on social media.

twitter_logo_20px.jpg @JNJinnovation



Press Releases

Read our latest news.

  • Johnson & Johnson Innovation launches Singapore QuickFire Challenge Competition in collaboration with ETPL and SMART to accelerate solutions for diabetes and other metabolic diseases

    March 22, 2017

    Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., announced today a collaboration with A*STAR’s ETPL, through its Diagnostics Development Hub, and Singapore-MIT Alliance for Research and Technology (SMART), to launch the Singapore QuickFire Challenge – Metabolic Disease Innovation.
    This global competition, launched today at the 2017 Biopharma Asia Conference in Singapore, will award the entrepreneur, academic, and biotech researchers who submit the best ideas, technologies, or solutions holding the potential of making a major difference for the millions of people in Asia Pacific and around the world who suffer from metabolic diseases, such as diabetes and obesity.

  • Janssen Human Microbiome Institute Announces Multiple Collaborations to Accelerate the Translation of Microbiome Science into Health Solutions

    Cambridge, MA
    February 2, 2017

    Agreements with DayTwo, the Weizmann Institute of Science and Caelus Health Focus on Promoting Health through Microbiome Innovation

  • Johnson & Johnson Innovation, New York State, and New York Genome Center Collaborate to Launch JLABS in New York City

    New York City
    January 9, 2017

    Johnson & Johnson Innovation LLC, New York State, and the New York Genome Center today announced a collaboration to launch a new JLABS in New York City. Called JLABS @ NYC, the 30,000-square foot facility will be located at the New York Genome Center (NYGC) in Soho and will open in 2018. The project is receiving $17 million in New York State funding.  The site will be open to biotech, pharmaceutical, medical device and consumer health companies. A Quick Fire Challenge seeking companies working in these areas, particularly startups working on cross-sector solutions to prevent intercept or cure diseases, will be launched by Johnson & Johnson Innovation, with the winner(s) eligible for one year of residency at JLABS @ NYC.



Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.